Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unified inactivation-mineralization: An engineered bacterial platform for synergistic radio-immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Inhalational therapy of pulmonary infection <i>via</i> macrophage-targeted nanoemulsions.

Acta pharmaceutica Sinica. B·2026
Same author

A Morphology-Driven Cascade Delivery of Antigens for Potent T Cell Immunity.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Biomineralized nanoemulsion delivers mRNA for potent cancer immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Modulating nuclear stiffness and envelope barrier facilitates AAV nuclear entry and reduces immunogenicity.

Nature communications·2026
Same author

Selective autophagic degradation of glycolytic activator PFKFB3 contributes to maintaining intestinal epithelial barrier in inflammatory bowel disease.

International journal of molecular medicine·2025

Related Experiment Video

Updated: Dec 13, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.6K

Engineering nanoparticulate vaccines for enhancing antigen cross-presentation.

Guangsheng Du1, Xun Sun1

  • 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610064, PR China.

Current Opinion in Biotechnology
|August 4, 2020
PubMed
Summary

Nanoparticle vaccines enhance the immune system's ability to present antigens (cross-presentation) for improved cancer and infectious disease vaccines. Strategies focus on nanoparticle design for better antigen delivery and immune response.

More Related Videos

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.9K

Related Experiment Videos

Last Updated: Dec 13, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.6K
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.9K

Area of Science:

  • Immunology
  • Nanotechnology
  • Vaccinology

Background:

  • Efficient cross-presentation is crucial for effective vaccination against intracellular pathogens and cancer.
  • Nanoparticle-based vaccines are being developed to enhance cross-presentation and CD8+ T cell priming.

Purpose of the Study:

  • To review intracellular pathways involved in cross-presentation.
  • To summarize nanoparticle strategies for enhancing cross-presentation.
  • To discuss future prospects of cross-presentation-based nanovaccine strategies.

Main Methods:

  • Review of existing literature on intracellular pathways and nanoparticle vaccine strategies.
  • Focus on nanoparticle design for endosomal escape, lymph node targeting, and co-delivery of immune modulators.

Main Results:

  • Nanoparticle strategies can enhance endosomal escape, improve antigen uptake by dendritic cells in lymph nodes, and upregulate cross-presentation pathways.
  • Multifunctional nanovaccines show promise for improved therapeutic outcomes.

Conclusions:

  • Nanoparticle-based approaches offer significant potential for developing advanced vaccines that improve cross-presentation.
  • Further research into nanovaccine design and immune modulation is warranted for disease treatment.